136 related articles for article (PubMed ID: 21391779)
1. Machine learning methods predict locomotor response to MK-801 in mouse models of down syndrome.
Nguyen CD; Costa AC; Cios KJ; Gardiner KJ
J Neurogenet; 2011 Mar; 25(1-2):40-51. PubMed ID: 21391779
[TBL] [Abstract][Full Text] [Related]
2. Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.
Siddiqui A; Lacroix T; Stasko MR; Scott-McKean JJ; Costa AC; Gardiner KJ
Genes Brain Behav; 2008 Oct; 7(7):810-20. PubMed ID: 19125866
[TBL] [Abstract][Full Text] [Related]
3. Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.
Ahmed MM; Dhanasekaran AR; Tong S; Wiseman FK; Fisher EM; Tybulewicz VL; Gardiner KJ
Hum Mol Genet; 2013 May; 22(9):1709-24. PubMed ID: 23349361
[TBL] [Abstract][Full Text] [Related]
4. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.
Costa AC; Scott-McKean JJ; Stasko MR
Neuropsychopharmacology; 2008 Jun; 33(7):1624-32. PubMed ID: 17700645
[TBL] [Abstract][Full Text] [Related]
5. Loss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome.
Ahmed MM; Sturgeon X; Ellison M; Davisson MT; Gardiner KJ
J Proteome Res; 2012 Feb; 11(2):1251-63. PubMed ID: 22214338
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
[TBL] [Abstract][Full Text] [Related]
7. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
8. Protein dynamics associated with failed and rescued learning in the Ts65Dn mouse model of Down syndrome.
Ahmed MM; Dhanasekaran AR; Block A; Tong S; Costa AC; Stasko M; Gardiner KJ
PLoS One; 2015; 10(3):e0119491. PubMed ID: 25793384
[TBL] [Abstract][Full Text] [Related]
9. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.
Gardiner KJ
Drug Des Devel Ther; 2015; 9():103-25. PubMed ID: 25552901
[TBL] [Abstract][Full Text] [Related]
11. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
12. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics of Down syndrome: a multidisciplinary approach.
Dierssen M; Martí E; Pucharcós C; Fotaki V; Altafaj X; Casas K; Solans A; Arbonés ML; Fillat C; Estivill X
J Neural Transm Suppl; 2001; (61):131-48. PubMed ID: 11771739
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
[TBL] [Abstract][Full Text] [Related]
16. Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome.
Chang P; Bush D; Schorge S; Good M; Canonica T; Shing N; Noy S; Wiseman FK; Burgess N; Tybulewicz VLJ; Walker MC; Fisher EMC
Cell Rep; 2020 Jan; 30(4):1152-1163.e4. PubMed ID: 31995755
[TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted.
Guedj F; Kane E; Bishop LA; Pennings JLA; Herault Y; Bianchi DW
Biol Psychiatry; 2023 Jul; 94(1):84-97. PubMed ID: 37074246
[TBL] [Abstract][Full Text] [Related]
19. Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration.
Watson-Scales S; Kalmar B; Lana-Elola E; Gibbins D; La Russa F; Wiseman F; Williamson M; Saccon R; Slender A; Olerinyova A; Mahmood R; Nye E; Cater H; Wells S; Yu YE; Bennett DLH; Greensmith L; Fisher EMC; Tybulewicz VLJ
PLoS Genet; 2018 May; 14(5):e1007383. PubMed ID: 29746474
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
